Opportunity

Simpler Grants.gov #FOR-AI-27-009

NIAID Resource-Related Research Projects Grant Opportunity

Buyer

National Institutes of Health

Posted

June 12, 2025

Respond By

January 26, 2026

Identifier

FOR-AI-27-009

NAICS

541715, 541714

The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), is inviting applications for the development of research resources to advance biomedical research: - Government Buyer: - National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) - Scope of Opportunity: - Investigator-initiated projects to create resources such as data, materials, tools, or services - Focus on infectious diseases, immune function/dysfunction, and translational research for vaccines, therapeutics, and diagnostics - Requirements: - Resources must be high quality, replenishable, and broadly available to qualified investigators - Projects must not duplicate existing commercial or other resources - Eligibility: - Open to educational institutions, nonprofits, government entities, and businesses - No specific OEMs, vendors, or commercial products are named, as this is a grant for resource development rather than a procurement of defined goods or services - Place of Performance: - National Institutes of Health (NIH)

Description

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to support investigator-initiated research projects that develop resources to serve biomedical research. These resources should provide data, materials, tools, or services essential for progress in fields related to NIAID's mission, including infectious diseases, immune function, and translational research for vaccines and therapeutics. Resources must be available to qualified investigators, be high quality, replenishable, and not duplicate existing commercial or other sources. The program encourages applications relevant to the biology, pathogenesis, immune response, and translational research of infectious and immune-mediated diseases.

View original listing